Even in the thrombolytic era, more than one-third of MIs are fatal within 24 hours

March 1995
Modern Medicine;Mar95, Vol. 63 Issue 3, p47
Presents an abstract of the article `Mortality Within 24 Hours of Thrombolysis For Myocardial Infarction: The Importance of Early Reperfusion,' by N.S. Kleiman, H.D. White, et al dated December 1994.


Related Articles

  • Review: PTCA reduces adverse cardiac outcomes and death better than thrombolytics after myocardial infarction. Keeley, E. C.; Boura, J. A.; Grines, C. L. // Evidence Based Medicine;Jul2003, p108 

    The article presents a research that compares the effectiveness of percutaneous transluminal coronary angioplasty (PTCA) and thrombolytic treatment in preventing death and adverse cardiac effects of acute myocardial infarction (MI) patients in the U.S. Researchers compared results of randomized...

  • Reducing mortality in myocardial infarction.  // BMJ: British Medical Journal (International Edition);4/16/2005, Vol. 330 Issue 7496, p856 

    Reports on the efforts of physicians to reduce the mortality rate of patients who have suffered myocardial infarction. How restoring blood flow promptly in occluded coronary arteries by either thrombolysis or angioplasty reduces mortality; How the United Kingdom does not have special funding...

  • Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation. Sabatine, Marc S.; Cannon, Christopher P.; Gibson, C. Michael; López-Sendón, Jose L.; Montalescot, Gilles; Theroux, Pierre; Claeys, Marc J.; Cools, Frank; Hill, Karen A.; Skene, Allan M.; McCabe, Carolyn H.; Braunwald, Eugene // New England Journal of Medicine;3/24/2005, Vol. 352 Issue 12, p1179 

    Background: A substantial proportion of patients receiving fibrinolytic therapy for myocardial infarction with ST-segment elevation have inadequate reperfusion or reocclusion of the infarct-related artery, leading to an increased risk of complications and death. Methods: We enrolled 3491...

  • The Thrombolysis In Myocardial Infarction risk index predicted in-hospital mortality in non-ST-segment elevation myocardial infarction.  // ACP Journal Club;Sep/Oct2006, Vol. 145 Issue 2, p52 

    The article focuses on a study which examines the role of Thrombolysis In Myocardial Infarction risk index (TRI) in predicting in-hospital mortality in patients with non-ST-segment elevation myocardial infarction (NSTEMI). The National Registry of Myocardial Infarction database was analyzed for...

  • COMMENTARY: The Thrombolysis In Myocardial Infarction risk index predicted in-hospital mortality in non-ST-segment elevation myocardial infarction. Scott, Ian A. // ACP Journal Club;Sep/Oct2006, Vol. 145 Issue 2, p52 

    The article presents information on a study on the mortality of Myocardial Infarction (MI) patients. The study proved that thrombolysis in MI satisfies the following criteria of risk prediction rules: they should be validated in unselected patients rather than clinical trial participants; they...

  • Improving Door-to-Balloon Times in STEMI. Abrams, Jonathan // Clinical Cardiology Alert;Jan2007, Vol. 26 Issue 1, p6 

    MORTALITY RATES FOR PATIENTS WITH ACUTE ST-segment elevation myocardial infarction (STEMI) have been stable for a number of years, and it has been difficult to lower death rates with current conventional therapies. A major advance was the recognition that immediate or early percutaneous...

  • Eficacia y seguridad de la trombólisis intracoronaria con estreptoquinasa en pacientes con infarto agudo al miocardio. Navarro, José Roberto Durán; Acuña, Jorge; Ayache, Mauricio Kuri; Fernández, Carlos Rafael Sierra; Macías, Manuel Ben Adoniram Gaxiola; Valdés, Xenia Serrano // Archivos de Medicina de Urgencia de México;sep-dic2013, Vol. 5 Issue 3, p97 

    Introduction: Acute myocardial infarction remains one of the major causes of mortality worldwide. Recent advances have greatly reduced mortality; however, new challenges arise in the post-reperfusion era. The use of intracoronary thrombolysis arises again as an effective therapy in patients who...

  • Impact of a well-organized collaborative team approach on mortality in patients with ST-segment elevation myocardial infarction. Yaylalı, Yalın Tolga; Susam, İbrahim; Ateş, Akın; Dursunoğlu, Dursun // Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi;Dec2010, Vol. 10 Issue 6, p508 

    Objective: Fibrinolytic therapy remains a legitimate option for many patients presenting with acute ST-segment elevation myocardial infarction (STEMI). Shorter time- to- treatment for patients with STEMI administered fibrinolytic therapy has repeatedly been shown to reduce mortality. A...

  • Gender differences in management after acute myocardial infarction: not 'sexism' but a reflection of age at presentation. Williams, R. Ian; Fraser, Alan G.; West, Robert R. // Journal of Public Health;Sep2004, Vol. 26 Issue 3, p259 

    Objective To test whether women receive less intensive treatment and fewer risk stratification tests following acute myocardial infarction (MI), than men. Methods A retrospective study of medical records in all district general hospitals and tertiary referral centres for cardiology in Wales was...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics